2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation
… , Jafna Cox MD e , Paul Dorian MD k , David Gladstone MD g h , M. Sean McMurtry MD l ,
Girish M. Nair MBBS m , Louise Pilote MD n , Jean-Francois Sarrazin MD o , Mike Sharma MD i …
Girish M. Nair MBBS m , Louise Pilote MD n , Jean-Francois Sarrazin MD o , Mike Sharma MD i …
Canadian Cardiovascular Society position statement on the management of thoracic aortic disease
…, J Leipsic, T Lindsay, MS McMurtry… - Canadian Journal of …, 2014 - Elsevier
This Canadian Cardiovascular Society position statement aims to provide succinct perspectives
on key issues in the management of thoracic aortic disease (TAD). This document is not …
on key issues in the management of thoracic aortic disease (TAD). This document is not …
Stroke prevention in atrial fibrillation patients with chronic kidney disease
…, JW Eikelboom, KS Brimble, MS McMurtry… - Canadian Journal of …, 2013 - Elsevier
Chronic kidney disease (CKD) is prevalent in elderly patients with atrial fibrillation and is an
independent risk factor for stroke. Warfarin anticoagulation is efficacious for stroke …
independent risk factor for stroke. Warfarin anticoagulation is efficacious for stroke …
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific …
Methods A writing group was established with representation from the Council on Peripheral
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
Vascular Disease and Council on Cardiopulmonary, Critical Care, Perioperative and …
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation
…, JS Healey, P Khairy, K Leblanc, MS McMurtry… - Canadian Journal of …, 2020 - Elsevier
The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was
developed to aid clinicians in the management of these complex patients, as well as to …
developed to aid clinicians in the management of these complex patients, as well as to …
An abnormal mitochondrial–hypoxia inducible factor-1α–Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded …
Background— The cause of pulmonary arterial hypertension (PAH) was investigated in humans
and fawn hooded rats (FHR), a spontaneously pulmonary hypertensive strain. Methods …
and fawn hooded rats (FHR), a spontaneously pulmonary hypertensive strain. Methods …
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control
…, JA Cairns, P Dorian, AM Gillis, MS McMurtry… - Canadian Journal of …, 2012 - Elsevier
The Canadian Cardiovascular Society (CCS) published the complete set of 2010 Atrial
Fibrillation (AF) Guidelines in the January, 2011 issue of the Canadian Journal of Cardiology. …
Fibrillation (AF) Guidelines in the January, 2011 issue of the Canadian Journal of Cardiology. …
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis
The pulmonary arteries (PA) in pulmonary arterial hypertension (PAH) are constricted and
remodeled;. They have suppressed apoptosis, partly attributable to suppression of the bone …
remodeled;. They have suppressed apoptosis, partly attributable to suppression of the bone …
[HTML][HTML] Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
MS McMurtry, SL Archer, DC Altieri… - The Journal of …, 2005 - Am Soc Clin Investig
Pulmonary arterial hypertension (PAH) is characterized by genetic and acquired abnormalities
that suppress apoptosis and enhance cell proliferation in the vascular wall, including …
that suppress apoptosis and enhance cell proliferation in the vascular wall, including …
Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage …
ED Michelakis, MS McMurtry, XC Wu, JRB Dyck… - Circulation, 2002 - Am Heart Assoc
Background— Chronic hypoxic pulmonary hypertension (CH-PHT) is associated with
suppressed expression and function of voltage-gated K + channels (Kv) in pulmonary artery (PA) …
suppressed expression and function of voltage-gated K + channels (Kv) in pulmonary artery (PA) …